Background. Heparin and angiotensin-converting enzyme inhibitors can be used as a therapeutic option in diabetic nephropathy (DN). Although the mode of action is poorly understood, both agents may retard the progression of DN. Previously, we demonstrated that angiotensin II (Ang II) has an inhibitory effect on the production of heparan sulphate proteoglycan (HSPG) in mesangial cells (MCs). We have now studied the influence of heparin on the Ang II-induced intracellular Ca 2þ release and activation of nuclear factor kappa B (NF-B 
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Background. Heparin and angiotensin-converting enzyme inhibitors can be used as a therapeutic option in diabetic nephropathy (DN). Although the mode of action is poorly understood, both agents may retard the progression of DN. Previously, we demonstrated that angiotensin II (Ang II) has an inhibitory effect on the production of heparan sulphate proteoglycan (HSPG) in mesangial cells (MCs). We have now studied the influence of heparin on the Ang II-induced intracellular Ca 2þ release and activation of nuclear factor kappa B (NF-B). Methods. Human MCs were isolated from renal cortex and cultivated to measure Ca 2þ influx and NF-B activation.
Results. Stimulation of MCs with 100 nM Ang II resulted in a rapid increase in the intracellular Ca 2þ concentration ([Ca 2þ ] i ), followed by a decline to baseline level. The addition of heparin resulted in an oscillatory pattern of Ca 2þ influxes upon Ang II stimulation. Whereas the rapid increase in [Ca 2þ ] i was most likely due to release from intracellular stores, oscillations in [Ca 2þ ] i were dependent on the presence of extracellular Ca 2þ . Heparin alone did not induce Ca 2þ influx. Both the initial increase and the subsequent oscillations in [Ca 2þ ] i could be blocked by losartan. In MCs with chemically or enzymatically altered membrane-associated heparan sulphate glycosaminoglycan (HS-GAG), Ang II stimulation resulted in [Ca 2þ ] i oscillations. Interestingly, in these cells, the addition of heparin or GAG completely prevented [Ca 2þ ] i oscillations. Heparin inhibited NF-B activation in Ang II-stimulated MCs that expressed either normal or chemically altered GAG. Conclusions. These findings suggest that alterations in HS-GAG chemistry or metabolism under pathological
Introduction
Diabetic nephropathy (DN) is characterized by mesangial matrix expansion, thickening of the glomerular basement membrane (GBM) and a concomitant loss of heparan sulphate proteoglycan (HSPG) in the mesangial matrix and the GBM. Hypertension is one of the main features of DN and is present in most, if not all, patients. During the last decade it has become evident that elevated blood pressure is the major determinant in the deterioration of renal function. The prognosis of DN is greatly improved by adequate treatment of hypertension using angiotensinconverting enzyme (ACE) inhibitors or angiotensin receptor antagonists.
In addition, evidence that heparin or heparan sulphate may have renoprotective effects in streptozotocin-induced diabetes in rats [1] and patients with overt DN [2] is accumulating. The studies of Gambaro et al. [1] and Oturai et al. [3] demonstrated that longterm administration of low-molecular-weight heparin and dermatan sulphate in diabetic rats prevented GBM thickening, glomerular anionic charge reduction and albuminuria. Treatment with sulphated glycosaminoglycans in patients with DN resulted in a reduction in urinary albumin excretion [2] .
It has been thought for a long time that the beneficial effects of ACE inhibition on the development and progression of DN are primarily related to the haemodynamic properties of these compounds. However, both in vitro and in vivo data support the notion that angiotensin II (Ang II) does affect intrinsic properties of the glomerular filtration barrier, independent of its haemodynamic properties [4] . It has been demonstrated that the production of transforming growth factor (TGF-) in mesangial cells (MCs) is induced by Ang II [5] , thereby indirectly stimulating the production of extracellular matrix (ECM) components. The inhibition of Ang II production may thus ameliorate renal disease by reducing renal TGFproduction. Moreover, Ang II is able to inhibit the production of HSPG in MCs [5] . As heparan sulphate can inhibit MC proliferation [6] , the loss of HSPG may then lead to an increased proliferation of MCs. Ang II may also directly stimulate MC proliferation [7] . Therefore, the beneficial effects of ACE inhibition or heparin on the development of DN may also be related to the inhibition of MC proliferation and the inhibition of TGF-production.
Little is known about the mechanisms by which heparin influences gene expression. However, several studies have provided evidence that heparan sulphate or heparin may interact with specific transcription factors [8] or interfere with signalling events in a variety of human cell lines. In addition, the action of a variety of growth factors (e.g. fibroblast growth factor and vascular endothelial growth factor) is known to be regulated by binding to heparan sulphate on the cell surface or the ECM, which promotes or restricts interactions with their signal transducing receptors.
Inasmuch as Ang II is able to influence the production of HSPG, nothing is known regarding the influence of HSPG on Ang II signalling. Therefore, we studied the effects of heparin on Ang II signalling in MCs. To this end, the intracellular Ca 2þ concentration [Ca 2þ ] i and activation of the Ca 2þ -dependent nuclear factor kappa B (NF-B) in Ang II-stimulated MCs were determined.
Materials and methods

Cell culture
MCs were cultured from normal renal tissue acquired from multiple sources, including from allografts unsuitable for transplantation and from grossly normal surgical nephrectomy specimens. MCs were isolated using standard methods described previously [9] . In brief, MCs were subcultured from hillocks, usually appearing 3 weeks after outgrowth of the glomeruli, in 24-well plates (Greiner, Frickenhausen, Germany) in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal calf serum (Gibco, Karlsruhe, Germany). Single wells were trypsinized and seeded into a T25-culture flask on the basis of cell morphology (multilayer, spindle shaped) and the absence of epithelial cells with cobblestone morphology. Depending on the cell density, cultures were divided and transferred by trypsinization into new T25-culture flasks. MCs were characterized after the third passage by a uniform staining with fluorescein isothiocyanate-phalloidin for actin, a positive staining with monoclonal antibodies against vimentin and the absence of staining using monoclonal antibodies against von Willebrand factor, cytokeratin and desmin. A purity of >95% was obtained after the third passage. Prior to each experiment, MCs were growth arrested by serum starvation for 24 h. For reasons of purity and senescence, only MCs in passages 4-8 were used in the experimental settings. MCs, grown on fibronectin-coated cover slips, were stimulated with Ang II in a concentration of 100 nmol/l in the absence or presence of 10-50 mg/ml heparin (Heparin Braun) or heparan sulphate glycosaminoglycan (HS-GAG). In some experiments the cells were cultured for 3 days in the presence of 25 mmol/l D-glucose or 25 mmol/l chlorate (NaClO 3 ) in sulphate-free medium before being stimulated with Ang II and/or heparin as described above. Heparinase and heparitinase treatment was performed by culturing MCs overnight in the presence of 10 U of heparinase and 1 U/ml of heparitinase, respectively.
Measurement of [Ca 2þ ] i
Cells were grown on round, fibronectin-coated glass cover slips for at least 2 days prior to each experiment. The cover slips were then washed twice in physiological saline solution (PSS) buffer (135 mmol/l NaCl, 5 mmol/l KCl, 1.8 mmol/l CaCl 2 , 0.8 mmol/l MgCl 2 , 10 mmol/l HEPES and 5.5 mmol/l glucose, pH 7.4) and then the MCs were loaded with 5 mmol/l Fura-2 AM in PSS buffer containing 10% Pluronic for 60 min at 37 C. Then, the cells were washed twice with PSS buffer to remove residual dye. The cover slips were placed in a thermostatically controlled chamber (37 C) containing 450 ml of PSS buffer. Ang II (100 nmol/l) was added alone or together with heparin (10-50 mg/ml) in a volume of 50 ml. A Zeiss Axiovert 35 (Zeiss, Hanau, Germany) inverted fluorescence microscope, equipped with a fluor 40/1.30 oil immersion objective and a charge-coupled device imaging camera (General Scanning, Planegg, Germany), was employed to detect fluorescence changes. Dual wavelength excitation at 340 and 380 nm was performed by an imaging system (Till Photonics, Planegg, Germany). The time increment was 3 s at an integration time of 200 ms for the 340 nm and 150 ms for the 380 nm excitation wavelength. Autofluorescence was determined in each experiment by the addition of 5 mmol/l ionomycin and 5 mmol/l MnCl 2 to quench intracellular dye. Calibration was performed according the method of Grynkiewicz [10] by use of the ratio for Fura-2 acid in solution at zero Ca 2þ (10 mmol/l EGTA) and the ratio at 1.8 mmol/l Ca 2þ . Typically, a region of 8-15 cells was monitored. All administered drugs were tested for autofluorescence, which was insignificant for these conditions of excitation and emission. All readings were checked for baseline stability for at least 90 s. The 340/380 nm ratio was analysed on serial images in regions of interest. Each experiment was performed at least five times with similar results.
Electrophoretic mobility shift assay
Nuclear proteins were isolated by lyses of 10 6 MCs in 200 ml of buffer A (10 mmol/l HEPES-KOH, pH 7.9, at 4 C, 1.5 mmol/l MgCl 2 , 10 mmol/l KCl, 0.5 mmol/l DTT and 0.2 mmol/l PMSF) for 10 min on ice. The supernatant was discarded and the pellet was resuspended in 50 ml of cold buffer C (10 mmol/l HEPES-KOH, pH 7.9, 25% glycerol, 420 mmol/l NaCl, 1.5 mmol/l MgCl 2 , 0.2 mmol/l EDTA, 0.5 mmol/l DTT and 0.2 mmol/l PMSF), incubated on ice for 20 min and centrifuged at high speed for 2 min at 4 C. The supernatant was quick frozen in liquid nitrogen and stored at -80 C until use. Protein concentrations were determined by Pierce reagent (Pierce, Rockford, IL). Briefly, NF-B consensus oligonucleotides were labelled to a specific activity of >5 Â 10 7 c.p.m./mg DNA using T4-polynucleotide kinase (Promega, Mannheim, Germany). Binding of NF-B was performed in 10 mmol/l HEPES, pH 7.5, 0.5 mmol/l EDTA, 100 mmol/l KCl, 2 mmol/l DTT, 2% glycerol, 4% Ficoll 400, 0,25% NP-40, 1 mg/ml bovine serum albumin (DNase free) and 0.1 mg/ml poly dI/dC in a total volume of 20 ml. Labelled oligonucleotide (1 ng) was added to 10 mg of nuclear extract and incubated at room temperature for 20 min in the appropriate binding buffer. Protein-DNA complexes were separated from the free DNA probe by electrophoreses through 5% native polyacrylamide gels containing 2.5% glycerol and 0.5Â TBE. The gels were run at room temperature with 30 mA for 2.5 h. Gels were dried on Whatmann D-81 paper (Schleicher und Schu¨ll, Dassel, Germany) and exposed for 12-48 h to Amersham Hyperfilms at -80 C.
Statistical analysis
The significance of changes in Ca 2þ responses between MCs stimulated with Ang II and those stimulated with Ang II plus heparin was assessed by application of the 2 test. P-values of <0.05 were considered to be significant. Results have been expressed as Mean ± SD.
Results
Influence of heparin or HS-GAG on Ang II-induced Ca 2þ signalling
The addition of 100 nmol/l Ang II to MCs immediately resulted in a rapid increase of [Ca 2þ ] i , followed by a gradual decline to baseline level ( Figure 1A ). Decreasing concentrations of Ang II resulted in a decline in peak [Ca 2þ ] i and a slower return to baseline (data not shown). As higher concentrations of Ang II (>100 nmol/l) did not differ from 100 nmol/l with respect to the increase in [Ca 2þ ] i , 100 nmol/l Ang II was used in all further experiments. When MCs were stimulated with a mixture of 100 nmol/l Ang II and 50 mg/ml heparin or HS-GAG (data not shown), the initial increase in [Ca 2þ ] i was followed by oscillations ( Figure 1B ). Although 10 mg/ml heparin also induced [Ca 2þ ] i oscillations in MCs, when stimulated with Ang II (data not shown), 50 mg/ml heparin was more effective in this respect and therefore used in all experiments. Oscillations in [Ca 2þ ] i were specific for heparin, as dextran sulphate was not able to influence Ang II-induced Ca 2þ signalling ( Figure 1C ). Similar negative findings for chondroitin sulphate were observed (data not shown). Statistical analysis of four independent experiments, in which a total number of 83 cells were analysed (37 stimulated with Ang II alone and 46 stimulated with Ang II plus heparin), revealed a highly significant correlation (P < 0.01) between Ang II stimulation in the presence of heparin and the occurrence of [Ca 2þ ] i oscillations. There was not a significant difference in the initial increase in [Ca 2þ ] i from baseline to peak between Ang II and Ang II plus heparin (113 ± 92 Á 340/380 and 143 ± 63 Á 340/380 nm, respectively) nor in the time to peak (14.4 ± 7.9 and 14.1 ± 10.6 s, respectively). Heparin was required during Ang II stimulation to exert a modulatory effect, as heparin preincubation and subsequent removal prior to Ang II stimulation did not change the Ang II response (data not shown). Both the initial increase and oscillations in [Ca 2þ ] i were exclusively mediated via the Ang II type 1 
Altered cell-associated HS-GAG expression changes Ang II-induced Ca 2þ signalling
Since the expression of HSPG is decreased in DN, we investigated whether an altered HSPG expression in MCs could change Ang II-induced Ca 2þ signalling. To this end, the expression of cell-associated HSPG was modulated in three ways. First, MCs were cultured for 3 days in the presence of 25 mmol/l D-glucose, which inhibits both the production of HSPG and its Nlinked sulphation [11] . Secondly, MCs were cultured in 25 mmol/l chlorate for 3 days to inhibit sulphation of HS-GAG [12] . Thirdly, MCs were cultured for 24 h in Figure 3D ). When MCs were cultured in medium alone, oscillations were induced by the Figure 3H ). Ang IIinduced oscillations in MCs that were cultured in Dglucose or chlorate were completely prevented by heparin ( Figure 3F and G), whereas heparin was without effect when the cells were cultured in the presence of heparitinase ( Figure 3H ).
Inhibition of NF-B by heparin
To investigate whether heparin was able to inhibit the nuclear translocation of NF-B in Ang II-stimulated MCs, the cells were stimulated with Ang II in the absence or presence of 50 mg/ml heparin. In nuclear extracts of MCs, three specific bands with apparent binding activity for NF-B consensus oligonucleotides were detected, as demonstrated by the disappearance of these bands when the extracts were preincubated with cold competitor oligonucleotides. The upper two bands were increased after Ang II stimulation in MCs that were either cultured under normal conditions or cultured in the presence of chlorate. Both bands consisted of NF-B p65, as the addition of anti-p65 antibody to the nuclear extract markedly decreased these bands and resulted in a super shift. Heparin completely prevented the increase in Ang II-mediated Fig. 4 . Heparin inhibits the angiotensin II (Ang II)-mediated activation of nuclear factor kappa B (NF-B). NF-B activation was studied by electrophoretic mobility shift assay as described in Materials and methods. To this end, MCs were either cultured in normal medium or medium supplemented with 50 mg/ml of heparin. The cells were also stimulated for 12 h with 100 nmol/l Ang II alone or together with 50 mg/ml heparin. Similar conditions were used in MCs that were cultured for 3 days in the presence of NaClO 3 . Specificity of shifted bands (large arrows) were demonstrated by preincubation of nuclear extracts from Ang II-stimulated cells with a 1000-fold excess of cold NF-B competitor oligonucleotides (C). Binding of the NF-B oligonucleotide was not influenced by a control oligonucleotide lacking the NF-B consensus sequence. Unspecific bands, as assessed by the binding of the control oligonucleotide, lacking the NF-B consensus sequence, are indicated by the small, dotted arrows. A supershift was performed by incubation of these extracts with NF-B anti-p65 monoclonal antibody prior to the addition of labelled NF-B oligonucleotides (arrowhead). Results of a representative experiment (n ¼ 3) are shown.
NF-B activation, as both p65-containing bands did not increase when MCs were stimulated with Ang II in the presence of heparin. No differences were found between normal MCs and those that were cultured in the presence of chlorate (Figure 4 ) or those that were cultured in the presence of 25 mmol/l D-glucose (data not shown).
Discussion
The ] i and heparin alone did not change it. In DN, the expression of HSPG is altered in both the GBM and mesangial matrix. Therefore, we investigated whether quantitative or qualitative alterations in HSPG expression could influence Ang IIinduced Ca 2þ signalling. We and others have previously demonstrated that glucose and chlorate alter cell-associated HS-GAG expression in MCs [11] and fibroblasts [12] . Ang II-induced [Ca 2þ ] i oscillations in MCs that were cultured in the presence of 25 mmol/l D-glucose or cultured in the presence of chlorate, suggesting that cell-bound HS-GAG may have a functional relevance in Ang II-induced Ca 2þ signalling. In contrast to MCs with unaltered HS-GAG expression, the addition of heparin to these cells completely normalized Ca 2þ signalling. These observations may be explained by the requirement of endogenous HS-GAG for normal AT1R activation. If this interaction does not occur, the receptor cannot be properly activated by Ang II, resulting in a change in Ca 2þ response. The interaction of HS-GAG with the AT1R may be disturbed by exogenous HS-GAG and desulphation of, or reduction in, endogenous HS-GAG. In the latter situation, the interaction with exogenous HS-GAG may restore a normal Ca 2þ signalling. Thus, in our view, oscillations always occur when the interaction of HS-GAG with the AT1R is disrupted. A discrete balance between membrane-associated HS-GAG and HS-GAG in the cell surrounding may therefore determine the pattern of Ca 2þ response after Ang II stimulation. In contrast to MCs cultured in the presence of 25 mmol/l Dglucose or 25 mmol/l chlorate, heparin was not able to restore a normal Ca 2þ response in heparitinase-treated MCs. It should be mentioned, however, that heparitinase treatment does not completely liberate the core protein from its HS-GAG side chains, but only acts on the N-acetylated or N-sulphated glucosamine-glucoronic linkage that has a sulphate group at the 6-position of the glucosamine moiety [14] . Heparitinase treatment would thus result in the generation of HS-GAG chains, varying in length, that are attached to the core protein.
We speculate that these HS-GAG stumps may prevent the interaction of exogenous HS-GAG with the AT1R, but may not be sufficient to enable a normal Ca 2þ response after Ang II stimulation.
There is evidence for the requirement of cell-bound HS-GAG in the activation of several receptors, including the basic fibroblast growth factor receptor [15] . These receptors cannot be activated in cell lines deficient in HS-GAG unless exogenous heparin is added, suggesting an absolute requirement for HS-GAG in receptor activation. The AT1R differs in this respect, as HS-GAG does not prevent or promote AT1R activation, but merely changes the Ca 2þ response that is evoked upon receptor engagement.
Several patterns of Ang II-induced increases in [Ca 2þ ] i have been observed in vascular smooth muscle cells, including a transient rise [16] , an initial peak followed by a low sustained plateau or an initial peak accompanied by discrete oscillations [17] . The differences in Ca 2þ response within one cell type using similar concentrations of Ang II may be explained by differences in HS-GAG expression among the vascular smooth muscle cells used in various laboratories. Our study clearly suggests that cell-bound HS-GAG plays an important role that may determine the pattern of Ca 2þ response displayed upon Ang II stimulation in MCs, although this may be different in vascular smooth muscle cells.
The AT1R is known to undergo agonist induced desensitization. Desensitization of the AT1R occurs independently of receptor internalization [18] and requires the activation of G protein-coupled receptor kinase (GRK). Although GRKs are heparin-sensitive kinases, our data do not support a role for receptor desensitization in [Ca 2þ ] i oscillations. First, to date, receptor desensitization could only be blocked by intracellular injection of heparin. Labelled heparin is taken up by cells and degraded with a half-time of several hours [19] . Thus, this process would be too slow to account for desensitization, as desensitization occurs within minutes. Secondly, if receptor desensitization was blocked by exogenous heparin, this would occur in MCs with both normal and altered HS-GAG expression. Therefore, oscillations in [Ca 2þ ] i should occur independently of the HS-GAG expressed in MCs, which was clearly not found in this study. Thirdly, oscillations also occur in heparitinase-treated MCs in the absence of heparin. Fourthly, heparin did not influence Ca 2þ signalling when MCs were stimulated with endothelin 1 (data not shown), which also signals through GRK.
The antimitogenic effects of heparin in MCs may be explained by the inhibition of Ca 2þ /calmodulindependent kinase II activation, the inhibition of c-fos induction or the inhibition of mitogen-activated protein kinase activation [8] . Moreover, oscillations in [Ca 2þ ] i are known to affect the activation of the calmodulindependent kinase II and subsequently influence gene expression [20] . 
